Cargando…
Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation
Development of simple and fully characterized immunomodulatory molecules is an active area of research to enhance current immunotherapies. Monophosphoryl lipid A (MPL), a nontoxic lipidic derivative from bacteria, is the first and currently only adjuvant approved in humans. However, its capacity to...
Autores principales: | Colombani, Thibault, Haudebourg, Thomas, Decossas, Marion, Lambert, Olivier, Ada Da Silva, Grace, Altare, Frederic, Pitard, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702646/ https://www.ncbi.nlm.nih.gov/pubmed/31453059 http://dx.doi.org/10.1002/advs.201900288 |
Ejemplares similares
-
704/DNA vaccines leverage cytoplasmic DNA stimulation to promote anti-HIV neutralizing antibody production in mice and strong immune response against alpha-fetoprotein in non-human primates
por: Colombani, Thibault, et al.
Publicado: (2023) -
Oral Delivery of miRNA With Lipidic Aminoglycoside Derivatives in the Breastfed Rat
por: Beuzelin, Diane, et al.
Publicado: (2019) -
Itaconate: A Potent Macrophage Immunomodulator
por: Li, Zeyu, et al.
Publicado: (2023) -
Editorial: Immunomodulation of Innate Immune Cells
por: Almeida, Catarina R., et al.
Publicado: (2020) -
Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction
por: Rezaeeyazdi, Mahboobeh, et al.
Publicado: (2022)